Edit Entry | Edit CV

Anna N. A. Tosteson, ScD

Title(s)
Professor of Health Policy and Clinical Practice
Professor of Medicine
Professor of Community and Family Medicine
James J. Carroll 1948 Professor of Oncology

Additional Titles/Positions/Affiliations
Director, Comparative Effectiveness Research Program, The Dartmouth Institute for Health Policy and Clinical Practice
Associate Director for Population Sciences, Dartmouth Cancer Center
Principal Investigator, SYNERGY, Dartmouth's Clinical and Translational Science Institute

Department(s)
Health Policy and Clinical Practice
Medicine
Community and Family Medicine

Education
Biostatistics (Health Decision Sciences), Harvard University, ScD
Biostatistics, Harvard University, MS
Statistics & Biometry, Cornell University, BS

Programs
Dartmouth Cancer Center
SYNERGY
The Dartmouth Institute for Health Policy and Clinical Practice

Contact Information

Geisel School of Medicine at Dartmouth
HB7505
One Medical Center Drive
Lebanon NH 03756

Office: WTRB 526, DHMC
Phone: 603-646-5664
Email: Anna.Tosteson@dartmouth.edu

Assistant: Christopher Jacobs
Asst. Phone: 603-646-5237
Asst. Email: Christopher.R.Jacobs@Dartmouth.EDU


Professional Interests

Dr. Anna Tosteson is a decision scientist and health services researcher who studies how the diffusion of innovations in health care are changing health, costs and quality of care. Through study of diverse data sources including registries, electronic health record data, clinical and epidemiological studies, and administrative claims data, she seeks insights into the long-term clinical and economic effects of alternative approaches to health care delivery with a focus on cancer screening, musculoskeletal disease, and women’s health.

Grant Information

Promoting follow-up of abnormal cancer screening tests using population-based systems to support stepped care multilevel intervention. (NCI: U01CA225451 )

Risk-based breast cancer screening and surveillance in community practice. (NCI, P01CA154292)

Courses Taught

PH 119/121; QBS 140 Decision and Cost-Effectiveness Analysis


Selected Publications

 

Delays in Breast Cancer Surgical Care Following Oncology Surgeon Departures.
Cornelius SL, Scodari BT, O'Malley AJ, Brooks GA, Tosteson ANA, Schaefer A, Moen EL
Med Care. 2026 Sep 7; doi: 10.1097/MLR.0000000000002374. Epub 2026 Sep 7.
PMID: 42704831

Patient- and Physician-Identified Considerations for Clinical Implementation of a New Risk-Based Prediction Tool to Guide Surveillance Mammography in Breast Cancer Survivors.
Gunn CM, Boyer N, Sheikh S, Lee JM, Woloshin S, Specht JM, Hubbard RA, Aiello Bowles EJ, Tosteson ANA
JCO Oncol Pract. 2026 May 29;:OP2501048. doi: 10.1200/OP-25-01048. Epub 2026 May 29.
PMID: 42214050

Understanding residential socioeconomic and behavioral patterns for home air radon testing: a population-based intervention study in New Hampshire and Vermont (USA).
Hasson RM, Fay KA, Weiss JE, Clement LM, Thompson ME, Schiffelbein JE, Hoopes PJ, Chidawanyika T, Tosteson ANA, Rees JR
Environ Health. 2026 May 26;25(1) doi: 10.1186/s12940-025-01260-w. Epub 2026 May 26.
PMID: 42192410

Telehealth Infrastructure for Cancer Care in the United States.
Liu L, Onega T, Moen EL, Tosteson ANA, Smith RE, Wang Q, Cowan L, Wang F
Sci Data. 2026 Mar 16;13(1) doi: 10.1038/s41597-026-07063-z. Epub 2026 Mar 16.
PMID: 41839934

Outcomes of Density-Targeted Supplemental Breast Magnetic Resonance Imaging Screening by Breast Cancer Risk: Long-Term Health and Economic Considerations.
Tosteson ANA, Stout NK, Su YR, van Ravesteyn NT, Lowry KP, Abraham L, Alagoz O, DiFlorio-Alexander R, de Koning HJ, Hampton JM, Henderson L, Mandelblatt JS, Onega T, Schechter CB, Sprague BL, Stein S, Trentham-Dietz A, Miglioretti DL, Kerlikowske K, Lee CI
Ann Intern Med. 2026 Apr;179(4):486-496. doi: 10.7326/ANNALS-25-00792. Epub 2026 Mar 3.
PMID: 41771133

Advanced Versus Invasive Breast Cancer Risk in a Screening Population: Implications for Risk-based Prevention and Screening Strategies.
Sprague BL, Gard CC, Chen S, Tice JA, Tosteson ANA, Perry H, Lee CI, Miglioretti DL, Kerlikowske K
J Gen Intern Med. 2026 Sep;41(12):3329-3338. doi: 10.1007/s11606-026-10237-5. Epub 2026 Feb 18.
PMID: 41709076

Five-Year Absolute Risk-Based and Age-Based Breast Cancer Screening in the US.
Alagoz O, Lu Y, Gil Quessep E, Kerlikowske K, Mandelblatt JS, Sprague BL, Trentham-Dietz A, Hampton J, Groeneweg R, de Koning HJ, Miglioretti DL, Schechter CB, van Ravesteyn NT, Tosteson ANA, Stout NK, Lowry KP
JAMA Netw Open. 2026 Jan 2;9(1):e2552944. doi: 10.1001/jamanetworkopen.2025.52944. Epub 2026 Jan 2.
PMID: 41557352

Outcomes Among Medicare Beneficiaries After Cancer Surgery in Hospitals That Subsequently Closed.
Kim MY, Staiger DO, Brooks GA, Wang Q, Wong SL, Tosteson ANA
JAMA Netw Open. 2026 Jan 2;9(1):e2553704. doi: 10.1001/jamanetworkopen.2025.53704. Epub 2026 Jan 2.
PMID: 41528743

Changes in patient-sharing patterns after oncologist departures in rural and urban settings: a Medicare cohort study.
Cornelius SL, O'Malley AJ, Brooks GA, Tosteson ANA, Schaefer A, Moen EL
Appl Netw Sci. 2026;11(1):1. doi: 10.1007/s41109-025-00762-3. Epub 2025 Dec 2.
PMID: 41509684

Use of Ecological Momentary Assessment to Measure Affect-Based Feeling States Among Rural Breast Cancer Survivors: A Feasibility Study Guided by the Integrated Screening Action Model.
St Angelo M, Stevens CJ, Beidler LB, Emond JA, Tosteson ANA, Gunn CM
Int J Behav Med. 2026 Aug;33(4):517-528. doi: 10.1007/s12529-025-10407-5. Epub 2025 Oct 27.
PMID: 41145781

View more publications on PubMed